Position in SNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,261,197
-$2,324,045 QoQ
Shares Held
615,593
+3.8% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#49
of 712 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen Capital Management, LLC holds $1,067,869,600 across 8 Drug Manufacturers - General names. SNY ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
2,033,040 | $318,618,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,099,077 | $279,132,585 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,016,795 | $259,158,157 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,132,367 | $65,246,986 | |
| 5 | PFE |
Pfizer Inc
|
2,447,200 | $58,928,576 | |
| 6 | NVO |
Novo Nordisk A S
|
1,224,955 | $58,724,342 | |
| 7 | SNY |
Sanofi
This page
|
615,593 | $26,261,197 | |
| 8 | ABBV |
AbbVie Inc.
|
7,152 | $1,799,729 |
All Filings in SNY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,261,197 | 615,593 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $28,585,242 | 593,301 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,483,253 | 360,777 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,147,550 | 384,482 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $21,151,277 | 437,824 | Shares | Sole | 2025-09-30 | |
| 2025-03-31 | $22,245,560 | 401,110 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,593,431 | 261,112 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $16,743,532 | 290,535 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,835,418 | 367,589 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,094,557 | 372,316 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,914,263 | 239,579 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $41,871,384 | 780,600 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $41,214,688 | 764,651 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $41,313,323 | 759,157 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $26,712,438 | 551,568 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $18,508,706 | 486,815 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $40,774,099 | 814,993 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $40,017,527 | 779,461 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $34,499,811 | 688,619 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $38,245,571 | 793,312 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $42,104,934 | 799,562 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $43,921,172 | 888,014 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||